SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Direct eye injection shows promise for treating fungal infections
Disease control CompletedThis study tested if injecting the antifungal drug fluconazole directly into the cornea is safe and effective for treating fungal keratitis, a serious eye infection. 40 patients with lab-confirmed fungal infections that were sensitive to fluconazole took part. The researchers mea…
Matched conditions: SAFETY
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Immune cell therapy shows promise in early trial for advanced cancers
Disease control CompletedThis early-phase study tested whether a treatment made from a patient's own immune cells (tumor-infiltrating lymphocytes) is safe for people with advanced solid tumors like melanoma, cervical cancer, and lung cancer. 43 participants received the therapy to find the best dose and …
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Immune cells from your own tumor: a new hope for advanced melanoma?
Disease control CompletedThis study tested a treatment called GC101 TIL for people with advanced melanoma that had stopped responding to standard therapies. Doctors took immune cells from each patient's own tumor, multiplied them in a lab, and gave them back to the patient. The goal was to see if this ap…
Matched conditions: SAFETY
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC
-
New supplement shows promise for stress and sleep in healthy adults
Symptom relief CompletedThis study tested a new supplement called KGA-10 (a heat-killed bacterium) in 107 healthy adults. Participants took either the supplement or a placebo daily for 8 weeks. Researchers measured stress, sleep quality, general well-being, and inflammation through surveys and blood sam…
Matched conditions: SAFETY
Phase: NA • Sponsor: Kioga Inc. • Aim: Symptom relief
Last updated Jun 16, 2026 12:50 UTC
-
Brain boost or just a pill? study tests supplements on student smarts
Symptom relief CompletedThis study looked at whether taking a dietary supplement for 60 days could improve thinking skills and mood in 75 university students. Participants were split into three groups: two received different supplements, and one got a placebo. Researchers measured changes in self-confid…
Matched conditions: SAFETY
Phase: NA • Sponsor: Cooperativa de Ensino Superior, Politécnico e Universitário • Aim: Symptom relief
Last updated Jun 15, 2026 18:54 UTC
-
Double eye numbing shot tested for Pain-Free cataract surgery
Symptom relief CompletedThis study tested a numbing injection given around both eyes to see if it safely controls pain during cataract surgery. Fifty adults received the injection, and researchers measured their pain and satisfaction. The goal was to find a better way to keep patients comfortable during…
Matched conditions: SAFETY
Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 12, 2026 12:08 UTC
-
Bike cameras reveal how kids really ride: safety program shows promise
Knowledge-focused CompletedThis study tested a community bike safety program for 195 kids ages 9 to 12. Some kids took a 12-hour safety class, some took the class plus a parent training session, and others received no training. All bikes were equipped with GPS and video cameras to track real-world riding b…
Matched conditions: SAFETY
Phase: NA • Sponsor: Cara J. Hamann • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
New probiotic passes safety check in early human trial
Knowledge-focused CompletedThis study checked whether a specific oral probiotic (Streptococcus salivarius eK12) is safe for healthy adults to take. A total of 29 participants in Pakistan and Italy received the probiotic or a placebo. Researchers monitored for side effects and changes in vital signs, blood …
Matched conditions: SAFETY
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Can an online guide help dementia caregivers handle firearm safety?
Knowledge-focused CompletedThis study tested an online decision aid for 500 informal caregivers of people with dementia who have access to firearms. The goal was to see if the tool helps caregivers feel more prepared and confident in making safety decisions. The study did not provide any treatment for deme…
Matched conditions: SAFETY
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Pregnant women get both shots at once: is it safe?
Knowledge-focused CompletedThis study looked at whether it's safe for pregnant women to get the COVID-19 and flu vaccines at the same time or if they should wait 1-2 weeks between shots. About 100 pregnant women took part, and researchers tracked side effects and birth outcomes like preterm birth. The goal…
Matched conditions: SAFETY
Phase: PHASE4 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC
-
Pen or syringe? study tests easier way to give pasireotide
Knowledge-focused CompletedThis study tested if giving the drug pasireotide with a reusable pen works as well as using a traditional syringe. Forty healthy adults received single doses by both methods to compare drug levels and safety. The goal was to see if the pen is a reliable alternative for future pat…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: RECORDATI GROUP • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:10 UTC
-
Kratom under the microscope: first safety data in recreational opioid users
Knowledge-focused CompletedThis study looked at how safe kratom is and how the body processes it in healthy adults who have used opioids recreationally. 40 participants received single rising doses of kratom to monitor side effects and drug levels. The goal was to gather basic safety information, not to tr…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Altasciences Company Inc. • Aim: Knowledge-focused
Last updated Jun 11, 2026 11:57 UTC
-
New glutathione formula shows promise in small human trial
Knowledge-focused CompletedThis study looked at how well a new type of glutathione supplement (called LipoMicel) is absorbed by the body compared to standard versions. Sixteen healthy adults took the supplement daily for 30 days, and researchers measured levels in the blood and checked for safety. The goal…
Matched conditions: SAFETY
Phase: NA • Sponsor: Factors Group of Nutritional Companies Inc. • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC
-
Exosome injection safety checked in small study
Knowledge-focused CompletedThis early-stage study tested whether a purified exosome product (PEP) is safe when injected into the skin of healthy adults. Eight participants received the injection and were monitored for side effects. The goal was to check for any immediate reactions or lab changes, not to tr…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Clinical Testing of Beverly Hills • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:07 UTC
-
Fun learning boosts safety skills in preschoolers
Knowledge-focused CompletedThis study tested a new way to teach personal safety to 60 children aged 4-5. Half of the kids took part in a special program using games and activities based on multiple intelligences theory, while the other half had regular lessons. The program aimed to improve children's knowl…
Matched conditions: SAFETY
Phase: NA • Sponsor: Karabuk University • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:06 UTC
-
New drug Y-3 passes first safety check in small human study
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called Y-3 in 20 healthy adults. Participants received a single dose of either 40 mg, 60 mg, or a placebo. The goal was to measure drug levels in the blood and check for any side effects, not to treat a …
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 01, 2026 18:08 UTC